Research PaperCell-penetrating peptides as part of therapeutics used in cancer research
Under a Creative Commons license
open access
Abbreviations
ACM
acute myeloid leukemia
ACPP
activatable cell-penetrating peptide
ANG
Angiopep
ASO
antisense oligonucleotide
BBB
blood–brain-barrier
CPPs
cell-penetrating peptides
CPT
camptothecin
CRC
colorectal cancer
Cur
curcumin
EGFP
enhanced green fluorescent protein
EPS8
epidermal growth factor receptor pathway substrate no.8
GBM
glioblastoma
IA-TCH
intra-arterially-transient cerebral hyperfusion
Mad
multiple antigen domain
MDM
murine double minute
MMP
matrix metalloproteinase
MTX
methotrexan
NSCLC
non-small cell lung cancer
NLS
nuclear localization sequence
NRP
neuropilin
PCNA
proliferating cell nuclear antigen
PEI
polyethyleneimine
PIP2
phosphatidylinositol-bisphosphate
PPI
protein–protein interaction
PS
phosphatidylserine
PTX
paclitaxel
RNP
ribonucleoprotein
SCLC
small cell lung cancer
STAT3
signal transducer and activator of transcription 3
TLR
toll-like receptor
VEGF
vascular endothelial growth factor
Keywords
Cell-penetrating peptides
Peptide–drug conjugates
Drug delivery
Peptide therapeutics
Cancer therapy
Cited by (0)
© 2021 The Author(s). Published by Elsevier B.V.